
import { ProductDetails } from "@/types/productDetails";

export const SUBTLE_MEDICAL_PRODUCTS: ProductDetails[] = [
  {
    id: "subtle-mr",
    name: "SubtleMR",
    company: "Subtle Medical",
    category: "Image Enhancement",
    githubUrl: "https://github.com/DLinRT-eu/dlinrteu-website/tree/main/src/data/products/image-enhancement/subtle-medical.ts",
    description: "AI-powered solution for enhancing MRI images, allowing for faster scan times while maintaining or improving image quality through noise reduction and resolution enhancement.",
    features: ["Deep learning enhancement", "MRI specific", "Scan time reduction", "Noise reduction"],
    certification: "FDA Cleared",
    logoUrl: "/logos/SubtleMedical.jpg",
    companyUrl: "https://subtlemedical.com/",
    productUrl: "https://subtlemedical.com/subtle-mr/",
    anatomicalLocation: ["Brain", "Body"],
    modality: "MRI",
    diseaseTargeted: ["Neurological disorders", "Musculoskeletal conditions", "Cancer"],
    releaseDate: "2019-08-19",
    version: "2.3.x",
    keyFeatures: [
      "Deep learning MRI enhancement",
      "Enables 2-4x faster scanning",
      "Improves SNR and image sharpness",
      "Works with multiple contrasts",
      "Vendor-neutral compatibility",
      "Supports all body parts MRI"
    ],
    technicalSpecifications: {
      population: "Adult and pediatric",
      input: ["DICOM MR images"],
      inputFormat: ["DICOM"],
      output: ["Enhanced MR images"],
      outputFormat: ["DICOM"]
    },
    technology: {
      integration: ["PACS", "Scanner integration"],
      deployment: ["Cloud-based", "On-premise"],
      triggerForAnalysis: "Automated workflow",
      processingTime: "<30 seconds per study"
    },
    regulatory: {
      ce: {
        status: "Approved",
        class: "IIa",
        type: "Medical Device",
        regulation: "MDR (EU 2017/745)"
      },
      fda: {
        status: "510(k) Cleared",
        class: "Class II",
        type: "510(k)",
        clearanceNumber: "K191688, K223623",
        regulationNumber: "21 CFR 892.2050",
        productCode: "LLZ",
        decisionDate: "2023-05-11"
      },
      intendedUseStatement: "SubtleMR is an image processing software that can be used for image enhancement of MRI images. It can be used for noise reduction and increasing image sharpness."
    },
    market: {
      onMarketSince: "2019",
      distributionChannels: ["Direct sales", "Distribution partners"]
    },
    clinicalEvidence: "Multiple peer-reviewed studies showing diagnostic equivalence between standard acquisition and accelerated protocols with SubtleMR enhancement",
    lastUpdated: "2025-01-27",
    lastRevised: "2026-01-27",
    source: "FDA 510(k) database (K191688, K223623) and company website"
  },
  {
    id: "subtle-pet",
    name: "SubtlePET",
    company: "Subtle Medical",
    category: "Image Enhancement",
    githubUrl: "https://github.com/DLinRT-eu/dlinrteu-website/tree/main/src/data/products/image-enhancement/subtle-medical.ts",
    description: "AI-powered PET image enhancement technology that enables faster scan times or lower dose while maintaining diagnostic image quality across multiple radiotracers.",
    features: ["Deep learning enhancement", "PET specific", "Dose reduction", "Multi-tracer support"],
    certification: "FDA Cleared",
    logoUrl: "/logos/SubtleMedical.jpg",
    companyUrl: "https://subtlemedical.com/",
    productUrl: "https://subtlemedical.com/subtle-pet/",
    anatomicalLocation: ["Whole body"],
    modality: "PET",
    diseaseTargeted: ["Cancer", "Neurological disorders", "Cardiovascular disease", "Prostate cancer"],
    releaseDate: "2018-11-30",
    version: "2.0",
    keyFeatures: [
      "Deep learning-based PET enhancement",
      "Enables 4x faster scans or 75% dose reduction",
      "Improved signal-to-noise ratio",
      "Enhanced lesion detectability",
      "Compatible with all major PET/CT scanners",
      "Supports FDG, amyloid, 18F-DOPA, 18F-DCFPyL, Ga-68 Dotatate, Ga-68 PSMA radiotracers"
    ],
    technicalSpecifications: {
      population: "Adult and pediatric",
      input: ["DICOM PET images"],
      inputFormat: ["DICOM"],
      output: ["Enhanced PET images"],
      outputFormat: ["DICOM"]
    },
    technology: {
      integration: ["PACS", "Scanner workstations"],
      deployment: ["Cloud-based", "On-premise option"],
      triggerForAnalysis: "Automated workflow",
      processingTime: "<60 seconds per study"
    },
    regulatory: {
      ce: {
        status: "Approved",
        class: "IIa",
        type: "Medical Device",
        regulation: "MDR (EU 2017/745)"
      },
      fda: {
        status: "510(k) Cleared",
        class: "Class II",
        type: "510(k)",
        clearanceNumber: "K182336, K211964",
        regulationNumber: "21 CFR 892.1200",
        productCode: "KPS, LLZ",
        decisionDate: "2021-09-28"
      },
      intendedUseStatement: "SubtlePET is an image processing software that can be used for image enhancement in PET images. It can be used for noise reduction and increasing image sharpness for PET images acquired using FDG, amyloid, 18F-DOPA, 18F-DCFPyL, Ga-68 Dotatate, and Ga-68 PSMA radiotracers."
    },
    market: {
      onMarketSince: "2018",
      distributionChannels: ["Direct sales", "Distribution partners"]
    },
    clinicalEvidence: "Multiple peer-reviewed studies showing diagnostic equivalence between standard dose and low-dose/fast-scan protocols with SubtlePET enhancement",
    lastUpdated: "2025-01-27",
    lastRevised: "2026-01-27",
    source: "FDA 510(k) database (K182336, K211964) and company website"
  },
  {
    id: "aimify",
    name: "AiMIFY",
    company: "Subtle Medical",
    category: "Image Enhancement",
    githubUrl: "https://github.com/DLinRT-eu/dlinrteu-website/tree/main/src/data/products/image-enhancement/subtle-medical.ts",
    description: "AI-powered solution for enhancing gadolinium-based contrast agent MRI images, improving contrast-to-noise ratio and lesion visibility in brain imaging.",
    features: ["Deep learning enhancement", "Contrast enhancement", "Brain MRI", "GBCA optimization"],
    certification: "FDA Cleared",
    logoUrl: "/logos/SubtleMedical.jpg",
    companyUrl: "https://subtlemedical.com/",
    productUrl: "https://subtlemedical.com/aimify/",
    anatomicalLocation: ["Brain"],
    modality: "MRI",
    diseaseTargeted: ["Brain tumors", "Metastases", "Neurological disorders"],
    releaseDate: "2024-08-21",
    version: "1.0",
    keyFeatures: [
      "Deep learning contrast enhancement",
      "Improves contrast-to-noise ratio (CNR)",
      "Enhances contrast enhancement percentage (CEP)",
      "Improves lesion-to-brain ratio (LBR)",
      "Works with gradient echo, 3D BRAVO, 3D MPRAGE sequences",
      "Supports 2D T1 spin echo and T1 FLAIR"
    ],
    technicalSpecifications: {
      population: "Adult",
      input: ["Pre-contrast T1 MRI", "Post-contrast T1 MRI"],
      inputFormat: ["DICOM"],
      output: ["Enhanced contrast MR images"],
      outputFormat: ["DICOM"]
    },
    technology: {
      integration: ["PACS", "Scanner integration"],
      deployment: ["Cloud-based", "On-premise"],
      triggerForAnalysis: "Automated workflow",
      processingTime: "<45 seconds per study"
    },
    regulatory: {
      ce: {
        status: "Pending",
        class: "IIa",
        type: "Medical Device"
      },
      fda: {
        status: "510(k) Cleared",
        class: "Class II",
        type: "510(k)",
        clearanceNumber: "K240290",
        regulationNumber: "21 CFR 892.2050",
        productCode: "LLZ",
        decisionDate: "2024-08-21"
      },
      intendedUseStatement: "AiMIFY is an image processing software that can be used for image enhancement in MRI images. It can be used to increase contrast-to-noise ratio (CNR), contrast enhancement (CEP), and lesion-to-brain ratio (LBR) of enhancing tissue in brain MRI images acquired with a gadolinium-based contrast agent."
    },
    market: {
      onMarketSince: "2024",
      distributionChannels: ["Direct sales", "Distribution partners"]
    },
    clinicalEvidence: "FDA 510(k) clearance based on clinical validation studies demonstrating improved CNR and lesion visibility",
    lastUpdated: "2025-01-27",
    lastRevised: "2026-01-27",
    source: "FDA 510(k) database (K240290) and company website"
  },
  {
    id: "subtle-hd",
    name: "SubtleHD",
    company: "Subtle Medical",
    category: "Image Enhancement",
    githubUrl: "https://github.com/DLinRT-eu/dlinrteu-website/tree/main/src/data/products/image-enhancement/subtle-medical.ts",
    description: "AI-powered general-purpose MRI enhancement software for noise reduction and image sharpness improvement across all body parts.",
    features: ["Deep learning enhancement", "Noise reduction", "All body parts", "Image sharpness"],
    certification: "FDA Cleared",
    logoUrl: "/logos/SubtleMedical.jpg",
    companyUrl: "https://subtlemedical.com/",
    productUrl: "https://subtlemedical.com/subtle-hd/",
    anatomicalLocation: ["Brain", "Spine", "Body", "Extremities"],
    modality: "MRI",
    diseaseTargeted: ["Neurological disorders", "Musculoskeletal conditions", "Oncology", "General diagnostic imaging"],
    releaseDate: "2025-02-12",
    version: "1.0",
    keyFeatures: [
      "Deep learning-based noise reduction",
      "Image sharpness enhancement",
      "Supports all body parts MRI",
      "Vendor-neutral compatibility",
      "General-purpose MRI enhancement",
      "Improved diagnostic image quality"
    ],
    technicalSpecifications: {
      population: "Adult and pediatric",
      input: ["DICOM MR images"],
      inputFormat: ["DICOM"],
      output: ["Enhanced MR images"],
      outputFormat: ["DICOM"]
    },
    technology: {
      integration: ["PACS", "Scanner integration"],
      deployment: ["Cloud-based", "On-premise"],
      triggerForAnalysis: "Automated workflow",
      processingTime: "<30 seconds per study"
    },
    regulatory: {
      ce: {
        status: "Pending",
        class: "IIa",
        type: "Medical Device"
      },
      fda: {
        status: "510(k) Cleared",
        class: "Class II",
        type: "510(k)",
        clearanceNumber: "K243250",
        regulationNumber: "21 CFR 892.2050",
        productCode: "QIH",
        decisionDate: "2025-02-12"
      },
      intendedUseStatement: "SubtleHD is an image processing software that can be used for image enhancement of all body parts MRI images. It can be used for noise reduction and increasing image sharpness."
    },
    market: {
      onMarketSince: "2025",
      distributionChannels: ["Direct sales", "Distribution partners"]
    },
    clinicalEvidence: "FDA 510(k) clearance based on clinical validation studies demonstrating equivalent or improved diagnostic quality",
    lastUpdated: "2025-01-27",
    lastRevised: "2026-01-27",
    source: "FDA 510(k) database (K243250) and company website"
  }
];
